» Articles » PMID: 31671531

Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2019 Nov 2
PMID 31671531
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Type II topoisomerases are ubiquitous enzymes in all branches of life that can alter DNA superhelicity and unlink double-stranded DNA segments during processes such as replication and transcription. In cells, type II topoisomerases are particularly useful for their ability to disentangle newly-replicated sister chromosomes. Growing lines of evidence indicate that eukaryotic topoisomerase II (topo II) activity is monitored and regulated throughout the cell cycle. Here, we discuss the various roles of topo II throughout the cell cycle, as well as mechanisms that have been found to govern and/or respond to topo II function and dysfunction. Knowledge of how topo II activity is controlled during cell cycle progression is important for understanding how its misregulation can contribute to genetic instability and how modulatory pathways may be exploited to advance chemotherapeutic development.

Citing Articles

In Silico and In Vitro Investigation of Cytotoxicity and Apoptosis of Acridine/Sulfonamide Hybrids Targeting Topoisomerases I and II.

Badr M, Elmongy E, Elkhateeb D, Moemen Y, Khalil A, Ali H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598399 PMC: 11597879. DOI: 10.3390/ph17111487.


Human Topoisomerase IIα Promotes Chromatin Condensation Via a Phase Transition.

Wu M, Beck C, Lee J, Fulbright Jr R, Jeong J, Inman J bioRxiv. 2024; .

PMID: 39464128 PMC: 11507700. DOI: 10.1101/2024.10.15.618281.


High-Resolution Genome-Wide Maps Reveal Widespread Presence of Torsional Insulation.

Hall P, Mayse L, Bai L, Smolka M, Pugh B, Wang M bioRxiv. 2024; .

PMID: 39416127 PMC: 11482950. DOI: 10.1101/2024.10.11.617876.


Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment.

Urbancokova A, Hornofova T, Novak J, Salajkova S, Hubackova S, Uvizl A Elife. 2024; 12.

PMID: 39388244 PMC: 11466457. DOI: 10.7554/eLife.91304.


Structural insights into the assembly of type IIA topoisomerase DNA cleavage-religation center.

Liu K, Chen S, Chan N Nucleic Acids Res. 2024; 52(16):9788-9802.

PMID: 39077950 PMC: 11381327. DOI: 10.1093/nar/gkae657.


References
1.
Dawlaty M, Malureanu L, Jeganathan K, Kao E, Sustmann C, Tahk S . Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell. 2008; 133(1):103-15. PMC: 2693193. DOI: 10.1016/j.cell.2008.01.045. View

2.
Richter A, Strausfeld U, Knippers R . Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo. Nucleic Acids Res. 1987; 15(8):3455-68. PMC: 340741. DOI: 10.1093/nar/15.8.3455. View

3.
Gonzalez R, Lim C, Cole K, Bianchini C, Schools G, Davis B . Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells. Cell Cycle. 2011; 10(20):3505-14. PMC: 3356834. DOI: 10.4161/cc.10.20.17778. View

4.
Ye J, Lenain C, Bauwens S, Rizzo A, Saint-Leger A, Poulet A . TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell. 2010; 142(2):230-42. DOI: 10.1016/j.cell.2010.05.032. View

5.
Robinson H, Bratlie-Thoresen S, Brown R, Gillespie D . Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193. Cell Cycle. 2007; 6(10):1265-7. DOI: 10.4161/cc.6.10.4225. View